Keywords
How to Cite
Abstract
Introduction. Capsular contracture (CC) is the most frequent and clinically significant complication in both aesthetic and reconstructive surgery for breast cancer, requiring repeated surgery in most cases. Currently, studies are being conducted to determine indications for the prevention and conservative treatment of capsular contractures.
Materials and Methods. The study included 25 patients with capsular contracture grades II-III according to Baker after reconstructive plastic surgery for combined/complex treatment for breast cancer (BC), who underwent conservative treatment using botulinum toxin type A (BTA).
Results. The study included patients with an average age of 48.3 ± 0.6 years. Before the introduction of botulinum toxin type A, the capsule thickness was determined using ultrasound (US), and on average amounted to 1.94 ± 0.05 mm. The maximum number of repeated injections was 3 within 6 months. Patients who were administered BTA for stage II-III capsular contracture showed a positive effect in the form of decreased pain, decreased deformation of the reconstructed mammary gland, and after 2 months the therapeutic effect was maintained and the capsule thickness averaged 1.51±0.05 mm.
Conclusion. Injections of botulinum toxin type A may become a potential new method in the treatment of capsular contracture after reconstructive plastic surgery for breast cancer.
References
Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Состояние онкологической помощи населению России в 2022 году. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2022; (илл): 239.-ISBN: 978-5-85502-283-4. [Ed. by Kaprin A.D., Starinsky V.V., Shakhzadova A.O. The state of oncological care for the population of Russia in 2022. P.A. Herzen Moscow State Medical Research Institute - branch of the Federal State Budgetary Institution «NMIC of Radiology» of the Ministry of Health of the Russian Federation, Moscow. 2022; (ill): 239.-ISBN: 978-5-85502-283-4. (In Rus)].
ASPS Procedural Statistics Release. Plastic & Reconstructive Surgery. 2024; 154(3S): 1-41.-DOI: https://doi.org/10.1097/01.prs.0001028284.06979.be.-URL: https://www.plasticsurgery.org/documents/news/statistics/2023/plastic-surgery-statistics-report-2023.pdf.
Бересток Т.С., Зикиряходжаев А.Д., Ермощенкова М.В., et al. Осложнения после одномоментной одноэтапной и двухэтапной реконструкции имплантатами у больных раком молочной железы при проведении комбинированного/комплексного лечения. Онкология. Журнал им. П.А. Герцена. 2023; 12 (3); 54-61.-DOI: https://doi.org/10.17116/onkolog20231203154. [Berestok T.S., Zikiryakhodzhaev A.D., Ermoshenkova M.V., et al. Complications after simultaneous one-stage and two-stage implant reconstruction in patients with breast cancer during combined/complex treatment. P.A. Herzen Journal of Oncology. 2023; 12 (3); 54-61.-DOI: https://doi.org/10.17116/onkolog20231203154. (In Rus)].
Wagner D.S., Mirhaidari S.J. Capsulectomy, implant exchange, and placement of acellular dermal matrix is effective in treating capsular contracture in breast augmentation patients. Aesthet Surg J. 2021: 41; 304-312.-DOI: https://doi.org/10.1093/asj/sjaa267.
Headon H., Kasem A., Mokbel K. capsular contracture after breast augmentation: an update for clinical practice. Arch Plast Surg. 2015: 42; 532-543.-DOI: https://doi.org/10.5999/aps.2015.42.5.532.
Baker J.L.Jr., Owsley J.Q.Jr., Peterson R.A, eds. Augmentation mammaplasty. In: Symposium on Aesthetic Surgery of the Breast. St. Louis: Mosby. 1978: 256-263.
Susini P., Nisi G., Pierazzi D.M., et al. Advances on capsular contracture-prevention and management strategies: a narrative review of the literature. Plast Reconstr Surg Glob Open. 2023; 11(6): e5034.-DOI: https://doi.org/10.1097/GOX.0000000000005034.
Добрякова О.Б., Кузнецова Н.В., Кузнецов Ю.В. Способ открытой капсулотомии у пациенток с фиброзной капсулярной конрактурой 3-4 степени после увеличивающей маммопластики силиконовыми протезами. Патент на изобретение RU 2582459 C1, 27.04.2016. Заявка № 2015115222/14 от 22.05.2015. [Dobryakova O.B., Kuznetsova N.V., Kuznetsov Yu.V. Method of open capsulotomy in patients with fibrous capsular contracture of 3-4 degrees after augmenting mammoplasty with silicone prostheses. Patent for the invention RU 2582459 C1, 04/27/2016. Application No. 2015115222/14 dated 05/22/2015. (In Rus)].
Jakob V.L., Keck M., Lohmeyer J.A. Decreasing time intervals in recurring capsular contracture? A single center retrospective study over 6 years. Plast Reconstr Surg Glob Open. 2023; 11(3): e4872.-DOI: https://doi.org/10.1097/gox.0000000000004872.
Zikiryakhodzhaev A.D., Alekseeva G.S., Reshetov I.V., et al. Botulinum toxin type a as a tool for correcting capsular contracture after reconstructive breast surgery. Plast Reconstr Surg Glob Open. 2021; 9(1): 3372.-DOI: https://doi.org/10.1097/gox.0000000000003372.
Добрякова О.Б., Кузнецова Н.В. Результаты консервативного лечения фиброзной капсулярной контрактуры 2 степени. Медицина и образование в Сибири. 2014; 6: 34. [Dobryakova O.B., Kuznetsova N.V. Results of conservative treatment of fibrous capsular contracture of the 2nd degree. Journal of Siberian Medical Sciences. 2014; 6: 34. (In Rus)].
Kim S., Ahn M., Piao Y., et al. Effect of botulinum toxin type a on TGF-β/Smad pathway signaling: implications for silicone-induced capsule formation. Plast Reconstr Surg. 2016; 138(5): 821-829.-DOI: https://doi.org/10.1097/prs.0000000000002625.
Закиряходжаев А.Д., Алексеева Г.С., Старкова М.В., et al. Способ лечения клинически выраженной капсулярной контрактуры после установки силиконовых эндопротезов молочных желез. Патент на изобретение RU 2732308 C1, 15.09.2020. Заявка № 2020112663 от 27.03.2020. [Zakiryakhodzhaev A.D., Alekseeva G.S., Starkova M.V., et al. A method for the treatment of clinically pronounced capsular contracture after the installation of silicone breast endoprostheses. Patent for the invention RU 2732308 C1, 09/15/2020. Application No. 2020112663 dated 03/27/2020. (In Rus)].
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2025